Enel prevé unas inversiones brutas de 35.800 millones de euros para el periodo 2024 y 2026, centrándose en el negocio de redes, donde se dan unos marcos regulatorios “justos y estables”, y siendo menos intensivo en capital y riesgo en
Nueva vuelta de tuerca en el culebrón de OpenAI. La empresa de inteligencia artificial ha alcanzado un principio de acuerdo para la vuelta de Sam Altman como consejero delegado, días después de su
Los días 1-2 de noviembre de 2023 pasarán a la historia como las fechas de la primera conferencia sobre seguridad y regulación internacional de la inteligencia artificial, la AI Safety Summit.
In August 2023, researchers at POSTECH improved water electrolysis catalysts for green hydrogen, blending iridium, ruthenium, and osmium, enhancing performance but highlighting challenges in maintaining stability. The growing demand to develop sustainable and efficient resources has pushed for various innovations.
The global cell and gene therapy market size surpassed USD 15,460 million in 2022 and is estimated to be worth around USD 82,240 million by 2032, growing at a healthy CAGR of 18.3% between 2023 and 2032.
n recent years, East China's Shandong province has used photovoltaic power as an important means to optimize the local energy structure. Adapted to local conditions, the province also promotes photovoltaic construction by utilizing resources such as enterprise factories, rural residences and idle ponds with the aim to realize the coordinated development of photovoltaic power generation, new energy, animal husbandry, and leisure and entertainment.
Chinese companies above a designated size reported a 12.2 percent year-on-year increase in retail sales of gold, silver and other jewelry to 247.2 billion yuan ($34.4 billion) between January and September, a trade body said.
The growth rate, second only to the catering industry's 18.7 percent during the same period, is far higher than the average growth of total retail sales — at 6.8 percent — across China, said Ye Zhibin, president of the Gems & Jewelry Trade Association of China during an international jewelry summit held in Shanghai earlier this month.
With litigation spanning many countries, the COVID-19 vaccine giants remain engaged in a heated patent war. In the latest twist, Pfizer’s Comirnaty partner BioNTech chalked up a win as the European Patent Office (EPO) snatched back one of Moderna’s patents, ruling it invalid.
The patent in question protects “respiratory virus vaccines,” according to its listing in the European Patent Register. Opposers to the patent include BioNTech and Pfizer, as well as Sanofi, the listing notes.
